Rates of events such as all-cause death, heart attack, stroke, and hospitalization for chest pain, heart failure, and respiratory infections were comparable.
Trial shows that COVID vaccine doesn’t raise risk of poor outcomes in acute coronary syndrome patients
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Genetic vulnerability, air pollution may raise risk of COVID infection, severe outcomes
- COVID 2024-25 vaccines 33% protective against emergency room or urgent care visits, data reveal
- Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
- US flu season shows signs of peak